洛陽鉬業(03993.HK)擬對參股子公司不超2.89億美元融資提供擔保
格隆匯11月8日丨洛陽鉬業(03993.HK)公告,為充分享有未來新能源行業發展紅利,積極佈局新能源領域稀有資源產業鏈,公司擬參與佈局印尼鎳、鈷產業。公司擬通過受讓股權及增資等方式投資華越鎳鈷,2019年11月8日,公司第五屆董事會第九次臨時會議審議通過了《關於投資華越鎳鈷(印尼)有限公司並提供擔保的議案》。
投資完成後,公司將間接持有華越鎳鈷30%的股權。作為次投資的重要內容一,公司擬對於華越鎳鈷建設項目超出擬定註冊資2.6億美元外的項目建設資金需求,根據華越鎳鈷股東協議的約定直接或間接向華越鎳鈷提供股東借款或為華越鎳鈷融資提供不超過2.89億美元或等值外幣額度的擔保。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.